IL6 and congenital rubella syndrome: To further test this concept, other CD3-binding antibody fragments could be tested, and more importantly, already-existing antibodies which were shown to be toxic due to CRS or other side-effects might be able to be recycled in such a format due to the attenuation and modulation of both T-cell activation and IL-6-mediated signalling.